Allogeneic stem cell
Showing 9976 - 10000 of >10,000
Relapsed/Refractory Small Cell Lung Cancer Trial in Worldwide (Tarlatamab)
Recruiting
- Relapsed/Refractory Small Cell Lung Cancer
-
Birmingham, Alabama
- +78 more
Jan 18, 2023
Ovarian Clear Cell Carcinoma Trial in Wuhan (Sintilimab, Bevacizumab Biosimilar IBI305)
Recruiting
- Ovarian Clear Cell Carcinoma
- Sintilimab
- Bevacizumab Biosimilar IBI305
-
Wuhan, Hubei, ChinaTongji Hospital of Tongji Medical College, Huazhong University o
Apr 18, 2022
Stage IB Hepatocellular Carcinoma AJCC v8, Stage II Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC
Not yet recruiting
- Stage IB Hepatocellular Carcinoma AJCC v8
- +2 more
- Durvalumab
- Regorafenib
-
Gainesville, Florida
- +3 more
Jun 15, 2022
Mesial Temporal Lobe Epilepsy Trial in Rochester, Houston (Low Frequency Stimulation (LFS) of site with the Medtronic Percept PC
Not yet recruiting
- Mesial Temporal Lobe Epilepsy
- Low Frequency Stimulation (LFS) of site with the Medtronic Percept PC system
- Standard of Care (SOC) High Frequency Stimulation of the Anterior Nucleus of the Thalamus (ANT) with the Medtronic Percept PC system
-
Rochester, Minnesota
- +1 more
Nov 1, 2022
Sarcopenia, Osteopenia or Osteoporosis Trial in Singapore (PEMF)
Not yet recruiting
- Sarcopenia
- Osteopenia or Osteoporosis
- PEMF
-
Singapore, SingaporeAlexandra Hospital
Sep 12, 2021
Flu Vaccine in Preventing Influenza Infection in Healthy
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- trivalent influenza vaccine
- +2 more
-
Duarte, California
- +1 more
Nov 3, 2017
Squamous Cell Carcinoma of the Head and Neck Trial in Atlanta (VX15/2503, Ipilimumab, Nivolumab)
Recruiting
- Squamous Cell Carcinoma of the Head and Neck
- VX15/2503
- +2 more
-
Atlanta, GeorgiaEmory University Hospital Midtown
Mar 2, 2022
Giant Cell Arteritis (GCA) Trial in Worldwide (Upadacitinib, Corticosteroid (CS), Placebo)
Recruiting
- Giant Cell Arteritis (GCA)
- Upadacitinib
- +2 more
-
Huntsville, Alabama
- +173 more
Aug 23, 2022
Recurrent Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage II NSCLC Trial in United States (TG4010, Nivolumab)
Completed
- Recurrent Non-Small Cell Lung Carcinoma
- +5 more
- TG4010
- Nivolumab
-
Duarte, California
- +3 more
Oct 11, 2021
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6
Not yet recruiting
- Grade 3b Follicular Lymphoma
- +5 more
- Biospecimen Collection
- +9 more
- (no location specified)
Jun 6, 2023
Colorectal Tumors Trial in New York (Botensilimab, Balstilimab)
Not yet recruiting
- Colorectal Neoplasms
-
New York, New YorkWeill Cornell Medicine/NewYork-Presbyterian Hospital
Jan 24, 2023
Glioblastoma Multiforme Trial in Washington, Baltimore, Bethesda (Temozolomide, Subventricular Zone radiation, Neural Progenitor
Recruiting
- Glioblastoma Multiforme
- Temozolomide
- +2 more
-
Washington, District of Columbia
- +2 more
Sep 17, 2021
Improve the Informed Consent Process Trial in United States (Consent Form Specific Format 1, Consent Form Specific Format 2)
Completed
- Improve the Informed Consent Process
- Consent Form Specific Format 1
- Consent Form Specific Format 2
-
Duarte, California
- +22 more
Dec 6, 2022
Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States (JCAR017, Durvalumab,
Active, not recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- JCAR017
- +7 more
-
Duarte, California
- +17 more
Jan 13, 2023
Histological/ Immunohistological and Molecularpathological Types
Active, not recruiting
- Epulis
-
Graz, AustriaMedical University
Apr 5, 2022
NSCLC Trial in Goyang-si (BIBW 2992, simvastatin)
Completed
- Non-small Cell Lung Cancer
- BIBW 2992
- simvastatin
-
Goyang-si, Gyeonggi-do, Korea, Republic ofNational Cancer Center
Apr 4, 2022
Sclerotherapy and Bone Marrow Injection In Aneurysmal Bone Cyst
Not yet recruiting
- Orthopedic Disorder
- Sclerotherapy With Adjuvant Bone Marrow Injection In Management of Aneurysmal Bone Cyst
- (no location specified)
Jan 23, 2023
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)
Active, not recruiting
- BRCA1 Gene Mutation
- +5 more
- Durvalumab
- +3 more
-
Buffalo, New York
- +1 more
Jan 20, 2023
Total Knee Replacement Trial in Aarhus, Horsens, Silkeborg (Low-load blood flow restricted exercise)
Recruiting
- Total Knee Replacement
- Low-load blood flow restricted exercise
-
Aarhus, Aarhus N, Denmark
- +2 more
Dec 14, 2022
Central Venous Catheter Related Bloodstream Infection, Catheter-Related Infections, Bloodstream Infection Due to Central Venous
Recruiting
- Central Venous Catheter Related Bloodstream Infection
- +2 more
- clorhexidine gluconate bathing
-
Istanbul, Kadıköy, TurkeyIMU
Aug 12, 2023
Advanced Cervical Adenocarcinoma, Advanced Cervical Adenosquamous Carcinoma, Advanced Cervical Squamous Cell Carcinoma Trial in
Recruiting
- Advanced Cervical Adenocarcinoma
- +12 more
- Biospecimen Collection
- +11 more
-
Los Angeles, California
- +15 more
Aug 23, 2022
Kidney Transplant Rejection Trial (MDR-102, Immunosuppressive Agents)
Not yet recruiting
- Kidney Transplant Rejection
- MDR-102
- Immunosuppressive Agents
- (no location specified)
Apr 4, 2022
Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- +2 more
- Panitumumab
- +4 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Feb 16, 2023